Glatiramer Subcutaneous and Tolterodine Extended-Release Capsules
Determining the interaction of Glatiramer Subcutaneous and Tolterodine Extended-Release Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: glatiramer
Brand name: Copaxone, Glatopa
Synonyms: Glatiramer (injection), Glatiramer Acetate
Generic Name: tolterodine
Brand name: Detrol, Detrol LA
Synonyms: Tolterodine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Glatiramer Subcutaneous-Tolterodine Tablets
- Glatiramer Subcutaneous-Tolterodine Tartrate
- Glatiramer Subcutaneous-Tolterodine Tartrate Capsules
- Glatiramer Subcutaneous-Tolterodine Tartrate Tablets
- Glatiramer Subcutaneous-Tolvaptan
- Glatiramer Subcutaneous-Tolvaptan (Jynarque/Jinarc)
- Tolterodine Extended-Release Capsules-Glatopa
- Tolterodine Extended-Release Capsules-Glatopa injection
- Tolterodine Extended-Release Capsules-Glecaprevir and pibrentasvir
- Tolterodine Extended-Release Capsules-Gleevec
- Tolterodine Extended-Release Capsules-Glenmax PEB DM
- Tolterodine Extended-Release Capsules-Glenmax PEB DM FORTE